| Patients | |
---|---|---|
Characteristics | No. | % |
Age, years | Â | Â |
Median | 46 | Â |
Range | 11-72 | Â |
Sex | Â | Â |
Male | 104 | 75.4 |
Female | 34 | 24.6 |
EBV infection | Â | Â |
< 1000 copy | 116 | 84.1 |
≥1000 copy | 22 | 15.9 |
Tumor factors | Â | Â |
WHO histology | Â | Â |
I | 2 | 1.5 |
II | 99 | 71.7 |
III | 37 | 26.8 |
AJCC T category | Â | Â |
T1-2 | 100 | 72.5 |
T3-4 | 38 | 27.5 |
AJCC N category | Â | Â |
N0-1 | 78 | 56.5 |
N2-3 | 60 | 43.5 |
AJCC stage | Â | Â |
I | 6 | 4.4 |
II | 19 | 13.8 |
III | 64 | 46.4 |
IVa | 39 | 28.3 |
IVb | 10 | 7.3 |
Treatment factors | Â | Â |
IMRT alone | 25 | 18.1 |
IMRT + chemotherapy | 113 | 81.9 |
Chemotherapy manner | Â | Â |
Neoadjuvant chemotherapy | 43 | 31.2 |
Concurrent chemotherapy | 18 | 13.0 |
Concurrent +Adjuvant | 52 | 37.7 |